Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RASEF expression correlates with hormone receptor status in breast cancer.
Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Miwa T, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. Shibata M, et al. Among authors: takeuchi d. Oncol Lett. 2018 Dec;16(6):7223-7230. doi: 10.3892/ol.2018.9542. Epub 2018 Oct 3. Oncol Lett. 2018. PMID: 30546460 Free PMC article.
Expression of regulatory factor X1 can predict the prognosis of breast cancer.
Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. Shibata M, et al. Among authors: takeuchi d. Oncol Lett. 2017 Jun;13(6):4334-4340. doi: 10.3892/ol.2017.6005. Epub 2017 Apr 7. Oncol Lett. 2017. PMID: 28599435 Free PMC article.
Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells.
Shibata M, Kanda M, Tanaka H, Umeda S, Miwa T, Shimizu D, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. Shibata M, et al. Among authors: takeuchi d. Oncol Rep. 2017 Sep;38(3):1760-1766. doi: 10.3892/or.2017.5800. Epub 2017 Jul 10. Oncol Rep. 2017. PMID: 28713959
MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer.
Watanabe M, Shibata M, Inaishi T, Ichikawa T, Soeda I, Miyajima N, Takano Y, Takeuchi D, Tsunoda N, Kanda M, Kikumori T, Kodera Y, Nagino M. Watanabe M, et al. Among authors: takeuchi d. Oncol Lett. 2020 Nov;20(5):198. doi: 10.3892/ol.2020.12059. Epub 2020 Sep 4. Oncol Lett. 2020. PMID: 32963604 Free PMC article.
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan.
Morita S, Kikumori T, Tsunoda N, Inaishi T, Adachi Y, Ota A, Shibata M, Matsuoka A, Nakanishi K, Takeuchi D, Mizutani T, Shimokata T, Hayashi H, Maeda O, Ando Y. Morita S, et al. Among authors: takeuchi d. Int J Clin Oncol. 2018 Feb;23(1):195-200. doi: 10.1007/s10147-017-1177-z. Epub 2017 Aug 8. Int J Clin Oncol. 2018. PMID: 28791509 Clinical Trial.
385 results